Zevra Therapeutics, Inc. Fair Value Adjustment of Warrants
Zevra Therapeutics, Inc. (ZVRA) reported Fair Value Adjustment of Warrants of $4.75 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2024-11-13
- Zevra Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2024-09-30 was $4.75M.
- Zevra Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2024-06-30 was -$5.78M.
- Zevra Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2024-03-31 was -$3.63M, a 334.76% decline year-over-year.
- Zevra Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-12-31 was $4.35M.
- Zevra Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was $98.00K.
- Zevra Therapeutics, Inc. fair value adjustment of warrants for fiscal 2022 was -$15.16M, a 58403.85% decline from fiscal 2021.
- Zevra Therapeutics, Inc. fair value adjustment of warrants for fiscal 2021 was $26.00K, a 85.87% decline from fiscal 2020.
- Zevra Therapeutics, Inc. fair value adjustment of warrants for fiscal 2020 was $184.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $4.75M 10-Q · filed 2024-11-13 | -$1.03M derived: sum of 2 quarters · filed 2024-11-13 | -$4.66M 10-Q · filed 2024-11-13 | -$309.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2024-06-30 | -$5.78M 10-Q · filed 2024-08-14 | -$9.41M 10-Q · filed 2024-08-14 | -$5.05M derived: sum of 3 quarters · filed 2024-08-14 | -$8.73M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2024-03-31 | -$3.63M 10-Q · filed 2024-05-09 | $724.00K derived: sum of 2 quarters · filed 2024-05-09 | -$2.95M derived: sum of 3 quarters · filed 2024-11-13 | -$5.07M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $673.00K derived: sum of 2 quarters · filed 2024-11-13 | -$1.45M derived: sum of 3 quarters · filed 2024-11-13 | $98.00K 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | -$3.68M 10-Q · filed 2024-11-13 | $0.00 10-Q · filed 2023-11-07 | -$5.80M derived: sum of 2 quarters · filed 2024-11-13 | -$4.25M 10-Q · filed 2024-11-13 | $0.00 10-Q · filed 2023-11-07 | -$19.11M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$2.12M 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2023-08-14 | -$575.00K 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2023-08-14 | -$15.44M derived: sum of 3 quarters · filed 2024-08-14 | -$15.46M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $1.54M 10-Q · filed 2024-05-09 | $2.00K 10-Q · filed 2023-05-15 | -$13.32M derived: sum of 2 quarters · filed 2024-05-09 | -$13.34M derived: sum of 3 quarters · filed 2024-05-09 | -$13.37M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$14.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$14.89M derived: sum of 2 quarters · filed 2024-04-01 | -$14.92M derived: sum of 3 quarters · filed 2024-04-01 | -$15.16M 10-K · filed 2024-04-01 | -$328.00K 10-K · filed 2023-03-07 | |||
| 2022-09-30 | -$22.00K 10-Q · filed 2023-11-07 | -$54.00K derived: sum of 2 quarters · filed 2023-11-07 | -$295.00K 10-Q · filed 2023-11-07 | -$361.00K derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$32.00K 10-Q · filed 2023-08-14 | -$273.00K 10-Q · filed 2023-08-14 | -$339.00K derived: sum of 3 quarters · filed 2023-08-14 | -$671.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$241.00K 10-Q · filed 2023-05-15 | -$307.00K derived: sum of 2 quarters · filed 2023-05-15 | -$639.00K derived: sum of 3 quarters · filed 2023-05-15 | -$245.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$398.00K derived: sum of 2 quarters · filed 2023-03-07 | -$4.00K derived: sum of 3 quarters · filed 2023-03-07 | $26.00K 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | -$332.00K 10-Q · filed 2022-11-10 | $62.00K derived: sum of 2 quarters · filed 2022-11-10 | $92.00K 10-Q · filed 2022-11-10 | $211.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $394.00K 10-Q · filed 2022-08-12 | $424.00K 10-Q · filed 2022-08-12 | $543.00K derived: sum of 3 quarters · filed 2022-08-12 | $680.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $30.00K 10-Q · filed 2022-05-12 | $149.00K derived: sum of 2 quarters · filed 2022-05-12 | $286.00K derived: sum of 3 quarters · filed 2022-05-12 | $289.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $256.00K derived: sum of 2 quarters · filed 2022-03-31 | $259.00K derived: sum of 3 quarters · filed 2022-03-31 | $184.00K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $137.00K 10-Q · filed 2021-11-10 | $140.00K derived: sum of 2 quarters · filed 2021-11-10 | $65.00K 10-Q · filed 2021-11-10 | -$150.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $3.00K 10-Q · filed 2021-08-13 | -$72.00K 10-Q · filed 2021-08-13 | -$287.00K derived: sum of 3 quarters · filed 2021-08-13 | -$1.64M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$75.00K 10-Q · filed 2021-05-14 | -$290.00K derived: sum of 2 quarters · filed 2021-05-14 | -$1.64M derived: sum of 3 quarters · filed 2021-05-14 | -$1.62M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$1.57M derived: sum of 2 quarters · filed 2021-03-12 | -$1.54M derived: sum of 3 quarters · filed 2021-03-12 | -$2.00M 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | -$1.35M 10-Q · filed 2020-10-30 | -$1.33M derived: sum of 2 quarters · filed 2020-10-30 | -$1.78M 10-Q · filed 2020-10-30 | -$7.47M derived: sum of 4 quarters · filed 2020-10-30 | ||||
| 2019-06-30 | $21.00K 10-Q · filed 2020-08-12 | -$432.00K 10-Q · filed 2020-08-12 | -$6.12M derived: sum of 3 quarters · filed 2020-08-12 | -$10.59M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | -$453.00K 10-Q · filed 2020-05-13 | -$6.14M derived: sum of 2 quarters · filed 2020-05-13 | -$10.61M derived: sum of 3 quarters · filed 2020-05-13 | -$16.17M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$10.15M derived: sum of 2 quarters · filed 2020-02-28 | -$15.72M derived: sum of 3 quarters · filed 2020-02-28 | -$5.98M 10-K · filed 2020-02-28 | ||||
| 2018-09-30 | -$4.47M 10-Q · filed 2019-11-14 | -$10.03M derived: sum of 2 quarters · filed 2019-11-14 | -$289.00K 10-Q · filed 2019-11-14 | $421.00K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$5.56M 10-Q · filed 2019-08-13 | $4.18M 10-Q · filed 2019-08-13 | $4.89M derived: sum of 3 quarters · filed 2019-08-13 | $3.58M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $9.74M 10-Q · filed 2019-05-14 | $10.45M derived: sum of 2 quarters · filed 2019-05-14 | $9.14M derived: sum of 3 quarters · filed 2019-05-14 | $5.62M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $710.00K 10-K · filed 2018-03-30 | -$602.00K derived: sum of 2 quarters · filed 2018-11-09 | -$4.13M derived: sum of 3 quarters · filed 2018-11-09 | $3.09M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | -$1.31M 10-Q · filed 2018-11-09 | -$4.83M derived: sum of 2 quarters · filed 2018-11-09 | $2.38M 10-Q · filed 2018-11-09 | -$342.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$3.52M 10-Q · filed 2018-08-10 | $3.69M 10-Q · filed 2018-08-10 | $970.00K derived: sum of 3 quarters · filed 2018-08-10 | $2.27M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $7.22M 10-Q · filed 2018-05-11 | $4.49M derived: sum of 2 quarters · filed 2018-05-11 | $5.79M derived: sum of 3 quarters · filed 2018-05-11 | -$14.97M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$2.72M 10-K · filed 2018-03-30 | -$1.42M derived: sum of 2 quarters · filed 2018-03-30 | -$22.19M derived: sum of 3 quarters · filed 2018-03-30 | -$32.47M 10-K · filed 2018-03-30 | ||||
| 2016-09-30 | $1.30M 10-K · filed 2018-03-30 | -$19.46M derived: sum of 2 quarters · filed 2018-03-30 | -$29.74M 10-Q · filed 2017-11-09 | -$28.98M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-06-30 | -$20.76M 10-K · filed 2018-03-30 | -$31.04M 10-Q · filed 2017-08-10 | -$30.28M derived: sum of 3 quarters · filed 2018-03-30 | -$28.19M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-03-31 | -$10.28M 10-K · filed 2018-03-30 | -$9.51M derived: sum of 2 quarters · filed 2018-03-30 | -$7.42M derived: sum of 3 quarters · filed 2018-03-30 | $15.24M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2015-12-31 | $764.00K 10-K · filed 2017-03-10 | $2.85M derived: sum of 2 quarters · filed 2017-03-10 | $25.51M derived: sum of 3 quarters · filed 2017-03-10 | $27.28M 10-K · filed 2018-03-30 | ||||
| 2015-09-30 | $2.09M 10-K · filed 2017-03-10 | $24.75M derived: sum of 2 quarters · filed 2017-03-10 | $26.51M 10-Q · filed 2016-11-10 | $29.73M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | $22.66M 10-K · filed 2017-03-10 | $24.42M 10-Q · filed 2016-08-11 | $27.64M derived: sum of 3 quarters · filed 2017-03-10 | $29.83M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $1.76M 10-K · filed 2017-03-10 | $4.98M derived: sum of 2 quarters · filed 2017-03-10 | $7.17M derived: sum of 3 quarters · filed 2017-03-10 | $8.74M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | $3.22M 10-K · filed 2016-03-16 | $5.41M derived: sum of 2 quarters · filed 2016-03-16 | $6.98M derived: sum of 3 quarters · filed 2016-03-16 | $7.22M 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | $2.19M 10-K · filed 2016-03-16 | $3.76M derived: sum of 2 quarters · filed 2016-03-16 | $4.00M 10-Q · filed 2015-11-13 | |||||
| 2014-06-30 | $1.57M 10-K · filed 2016-03-16 | $1.81M 10-Q · filed 2015-08-14 | ||||||
| 2014-03-31 | $242.00K 10-K · filed 2016-03-16 | |||||||
| 2013-12-31 | -$1.14M 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |